Biopsy of Prostate: Clinical Trials

11 trials of Biopsy of Prostate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 active not recruiting, 2 terminated, 2 withdrawn. 3 Early Phase 1, 3 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Early Phase 13Recruiting 2, Active not recruiting 1
Not applicable3Withdrawn 2, Active not recruiting 1
Phase 22Completed 1, Terminated 1
Phase 11Completed 1
Phase 31Not yet recruiting 1
Phase 41Recruiting 1

Follow Biopsy of Prostate: new trials by email Literature Review of Biopsy of Prostate trials Research Report on Biopsy of Prostate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
ultiparametric Magnetic Resonance Imaging, Perflutren lipid microsphere, Transrectal Ultrasound - Prostate Carcinoma
Phase 3Not yet recruitingThomas Jefferson University3002026-10-012026-08-25
Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy
Biopsy of Prostate, Magnetic Resonance Imaging, Micro-ultrasound Imaging - Prostate Carcinoma
Not applicableWithdrawnRoswell Park Cancer Institute2026-08-182026-10-29
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
Biopsy of Prostate, Biospecimen Collection, Computed Tomography - Prostate Carcinoma
Early Phase 1RecruitingJonsson Comprehensive Cancer Center302025-11-142026-03-10
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Biopsy of Prostate, Biospecimen Collection, Magnetic Resonance Imaging - Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8
Phase 4RecruitingRoswell Park Cancer Institute6002025-01-152026-05-14
Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial
Buffered Lidocaine (1% Lidocaine + 8.4% Sodium Bicarbonate, in a 3:1 ratio), Lidocaine, Biopsy of Prostate - Prostate Cancer
Phase 1 / Phase 2CompletedUniversity of Washington3502025-01-092026-02-17
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
Biopsy of Prostate, Decipher Prostate Cancer Test, Flotufolastat F-18 Gallium - Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8
Early Phase 1RecruitingNorthwestern University402023-06-072026-07-02
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
Biopsy of Prostate, Gallium Ga 68 Gozetotide, Transrectal Ultrasonography Guided Biopsy - Prostate Carcinoma
Early Phase 1Active not recruitingJonsson Comprehensive Cancer Center302022-01-132026-02-12
Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy
Biopsy of Prostate, Laboratory Biomarker Analysis - Stage III Prostate Adenocarcinoma
Not applicableWithdrawnJonsson Comprehensive Cancer Center2018-03-012020-07-24
Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA
Biopsy of Prostate, Laboratory Biomarker Analysis, Magnetic Resonance Imaging - Health Status Unknown, Elevated PSA
Not applicableActive not recruitingUniversity of Southern California2882017-09-252026-06-05
MRI Before Biopsy in Diagnosing Patients With Prostate Cancer
magnetic resonance imaging, prostate biopsy - Prostate Cancer
TerminatedCase Comprehensive Cancer Center1392014-09-102017-12-21
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
Biopsy of Prostate, Docetaxel, Laboratory Biomarker Analysis - Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma
Phase 2TerminatedOHSU Knight Cancer Institute112010-07-122019-10-02

Conditions studied

Prostatic Neoplasms (9)

Sponsors

Jonsson Comprehensive Cancer Center (3)  ·  Roswell Park Cancer Institute (2)  ·  Case Comprehensive Cancer Center (1)  ·  Northwestern University (1)  ·  OHSU Knight Cancer Institute (1)  ·  Thomas Jefferson University (1)  ·  University of Southern California (1)  ·  University of Washington (1)

Countries

United States (11)  ·  Netherlands (1)

Top investigators

Ahmed Aly (1)  ·  Alexander Zhu, DO (1)  ·  Ashley E Ross (1)  ·  Inderbir Gill (1)  ·  Jeremie Calais (1)  ·  Khurshid A Guru (1)  ·  Mitchell Kamrava (1)  ·  Robert Abouassaly (1)  ·  Tomasz Beer (1)  ·  Wayne Brisbane (1)

Results publications

PMID 40177325, PMID 41833067

NIH funding

P30CA014089 (1), P30CA043703 (1), P30CA060553 (1), P30CA069533 (1), R01CA205058 (1)